Table 1.
Baseline characteristics of sample size.
| Category | Variables | Patients with Myocarditis (n = 55) | Healthy Controls (n = 55) | p-Value |
|---|---|---|---|---|
| Clinical | Age, years | 46.4 ± 15.3 | 45.5 ± 16.7 | >0.05 |
| Male gender (%) | 40 (73%) | 41 (74.5%) | >0.05 | |
| HR, bpm | 90.4 ± 19.4 | 74.6 ± 11.3 | * | |
| SBP, mmHg | 118.7 ± 17.3 | 123.3 ± 7.8 | >0.05 | |
| DBP, mmHg | 78.4 ± 11.3 | 77.5 ± 4.9 | >0.05 | |
| BMI, kg/m2 | 27.5 ± 7.3 | 26.4 ± 4.8 | >0.05 | |
| Echocardiography | IVSd, mm | 9.5 ± 3.1 | 8.9 ± 3.3 | >0.05 |
| PWd, mm | 7.8 ± 3.7 | 7.4 ± 3.4 | >0.05 | |
| LVEDD, mm | 53.4 ± 5.4 | 46.3 ± 3.7 | * | |
| LVESD, mm | 31.5 ± 6.3 | 22.5 ± 3.3 | ** | |
| LVMi, g/m2 | 50.7 ± 6.4 | 46.5 ± 3.3 | >0.05 | |
| LVEF, % | 44.4 ± 5.7 | 54.4 ± 7.3 | ** | |
| SV, mL | 52.4 ± 16.1 | 80.4 ± 15.6 | ** | |
| CO, L/min | 3.7 ± 1.3 | 5.9 ± 2.1 | * | |
| E/A ratio | 1.8 ± 0.5 | 1.5 ± 2.5 | ** | |
| Average E/e’ | 13.9 ± 4.2 | 6.5 ± 3.5 | ** | |
| LAVi, mL/m² | 33.4 ± 5.3 | 28.3 ± 4.2 | * | |
| PASP, mmHg | 41.4 ± 4.3 | 22.4 ± 2.4 | ** | |
| Speckle tracking | GLS, % | −14.4 ± 5.2 | −22.1 ± 3.8 | ** |
| Epicardial GLS, % | −11.4 ± 5.8 | −21.4 ± 3.1 | *** | |
| Mid-wall GLS, % | −13.9 ± 4.3 | −22.4 ± 2.8 | ** | |
| Endocardial GLS, % | −15.9 ± 3.3 | −23.7 ± 4.8 | ** |
*: <0.05; **: <0.001; ***: <0.0001; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; IVSd: interventricular septum in diastole; PWd: posterior wall in diastole; LVEDD: left ventricular end diastolic diameter; LVESD: left ventricular end systolic diameter; LVMi: left ventricular mass index; LVEF: left ventricular ejection fraction (Simpson’s biplane); SV: stroke volume; CO: cardiac output; LAVi: left atrial volume index; PASP: pulmonary artery systolic pressure; GLS: global longitudinal strain.